WOCKPHARMA — Wockhardt Balance Sheet
0.000.00%
- IN₹251.20bn
- IN₹270.47bn
- IN₹33.73bn
Annual balance sheet for Wockhardt, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,810 | 900 | 5,050 | 5,340 | 6,620 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11,970 | 10,640 | 8,570 | 10,290 | 6,390 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25,890 | 22,080 | 21,840 | 25,690 | 26,970 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 28,600 | 24,360 | 23,090 | 22,310 | 22,890 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 82,430 | 76,830 | 76,490 | 81,350 | 86,150 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 32,070 | 34,350 | 27,910 | 20,420 | 16,220 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 43,940 | 43,290 | 42,900 | 37,820 | 36,750 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 38,490 | 33,540 | 33,590 | 43,530 | 49,400 |
| Total Liabilities & Shareholders' Equity | 82,430 | 76,830 | 76,490 | 81,350 | 86,150 |
| Total Common Shares Outstanding |